KEAP1 and cancer: In contrast to other cancers, we found no evidence for the existence of non-synonmous mutations in NRF2 or KEAP1 in our panel of cell lines, nor in publicly-available SAGE gene expression data from a panel of 24 advanced pancreatic adenocarcinomas [25].